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of DCs in HCV infection and shed light on the DC-based
immunotherapeutic strategy.
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Background: Liver failure usually progresses into a poor
mortality. Despite their accuracy, classic models including
model for end-stage liver disease (MELD) and Child Pugh
score (CPS), are mainly being accepted to determine the
prognosis of patients with end-stage liver disease, However,
these models are still controversial in predicting mortality
of patients with acute-on-chronic hepatitis B liver failure
(ACHBLF). In this study, we aim to evaluate the possibility
to better predict mortality of the hospitalized patients with
ACHBLF using a novel logistic regression model (LRM).
Methods: The LRM was constructed using data from 242
consecutive patients with ACHBLF at Liver Research Center,
Wenzhou, China (internal cohort). The LRM was tested
on 210 patients listed for medical treatment at Tianjin
Infectious Disease Hospital, China (external cohort). The
receiver operating characteristic curves (ROCs) were drawn
for LRM, MELD, CPS and Sun’s model. Predictions of
mortality obtained with four models on the same datasets
were compared using areas under ROC curves (AUC).
Result: In internal cohort, there were 75 patients who died
in hospital (31.0%). The mean MELD score for the patients
who died was signiﬁcantly greater than those who survived
(26.8 vs. 22.4, p < 0.001). The LRM performed excellent
diagnostic accuracy signiﬁcantly better than MELD, CPS and
Sun’s model both in the internal cohort (AUC = 0.873 vs.
0.694 vs. 0.718 vs. 0.786; p < 0.001, p < 0.001, p = 0.002,
respectively) and in the external cohort (AUC = 0.844 vs.
0.775 vs. 0.601 vs. 0.753; p = 0.035, p < 0.001, p = 0.004,
respectively).
Conclusion: Our newly established LRM was superior to
MELD, CPS and Sun’s model in predicting mortality risk of
hospitalized patients with ACHBLF.
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Objective: To explore the clinical proﬁle, biochemical
ﬁndings, complications and maternal outcome in patients
of acute fatty liver of pregnancy (AFLP).
Methods: Patients with AFLP hospitalized in Beijing Ditan
Hospital from Sep 1996 to Nov 2010 were analyzed. The
clinical feature, laboratory examination, and treatment
were retrospectively analyzed.
Results: There were 27 women included in this study with
a mean age of 27.7±3.3 years (23 to 34 years). The
mean gestational age was 35.9±2.2 weeks. There were
3 cases death (11.1%). The most common symptoms at
admission were jaundice (20 cases), fatigue (16 cases),
nausea and vomiting (13 cases) and pruritus (5 cases).
During hospital stay, three patients presented psychiatric
symptom, manifesting as visual hallucination, auditory
hallucination, and delusion of persecution. Laboratory
examination: WBC increased, anemia, thrombocytopenia,
hypoalbuminemia, the total bile acid increased, coagulation
dysfunction (PTA< 80%) and renal injury. Compared with
non-ALF group (n = 14), the ALF group (n = 13) patients have
higher white blood cell, TBIL, DBIL, Cr lever and lower
hemoglobin and PTA (P< 0.01). The ALF group patients were
more likely to present hypoglycemia, acute renal failure,
coagulation disorders, acute respiratory distress syndrome,
neonatal asphyxia, post-partum hemorrhage and fetal death
(P< 0.05). There are 24 cases discharged home with full
recovery of hepatic and renal function. Other three cases
were dead. The causes of death were cerebral hemorrhage,
post-partum hemorrhage, hemorrhagic shock and multiple
organ failure.
Conclusions: (1) Patients with ALF are more likely to occur
multiple organ dysfunction, asphyxia neonatorum and fetal
death. (2) With adequate support, the most patients may
have full recovery of hepatic and renal function.
PP-154 Alpha fetoprotein is a novel inhibitor of
apoptosis protein mediated human hepatoma
Bel 7402 cells resisting the apoptosis induced
by TRAIL
M.S. Li1 *, M.Y. Zhu1, X.J. Xie2. 1Key Laboratory of
Molecular Biology, Hainan Medical College, Haikou 571101,
Hainan Province, China, 2Department of Pathophysiology,
Hainan Medical College, Haikou 571101, Hainan Province,
China
Objective: AFP has a property to maintain hepatocellular
carcinoma cells (HCC) growth in vivo, and hepatitis B
virus X (HBX) protein up-regulates AFP expression in HCC,
but the critical function of AFP was unclear, the present
investigation explore the inﬂuence of AFP on the apoptosis
induced by tumor necrosis factor-related apoptosis-inducing
ligand (TRAIL) of HCC.
Methods: Co-localization and interactIon of AFP and
caspase-3 or caspase-8 observed by confocal microscopy
or co-immunoprecipitation (Co-IP); siRNA was applied to
knockdown the expression of AFP in Bel 7402 cells (AFP-
producing); The activity of caspase-3 or caspase-8 was
detected by protease activity colorimetric methods; Flow
cytometry and MTT were used to analyze apoptosis and
growth of the cells; and ﬂuorescent microscopy was used to
observe the apoptosis of Bel 7402 cells.
Results: AFP harbors a function to interact with caspase-3
in cytoplasm, but could not binding with caspase-8; The
activity of caspase-3 or caspase-8 was enhanced and the
expression of AFP was repressed when treated with all trans
retinoic acid (40mmol/L) plus TRAIL (2nmol/L); Treated
with TRAIL (2nmol/L) alone, the activity of caspase-8 was
promoted and activity of caspase-3 has not any alteration;
AFP was able to inhibit the activity of caspase-3 but it has
any effect on the activity of caspase-8 in vitro; Bel 7402 cells
resisted the apoptosis induced by TRAIL (2nmol/L); While
knockdown AFP expression by siRNA followed treatment
with TRAIL (2nmol/L), caspase-3 activity was increased but
caspase-8 activity had not any change, and Bel 7402 cells
growth were inhibited (ratio 48.4%), and TRAIL could induce
the apoptosis of the cancer cells.
Conclusions: AFP inhibits caspase-3 activity is the pivotal
events that AFP mediated HCC resists apoptosis induced
by TRAIL.
